Researchers at Lund University have validated a blood-based method for measuring circulating tumor DNA in patients with early ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So patients in the first relapse after the ...

Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. While some patients respond well to standard treatments, others experience an early relapse, often within 18 ...

Panelists discuss how early relapse in standard-risk patients represents a failure of current risk assessment methods and may require advanced sequencing technologies to identify hidden high-risk ...

Diffuse large B-cell lymphoma is a common type of non-Hodgkin’s lymphoma that also has a high rate of relapse. Common signs of a relapse include lymph node swelling, as well as the development of “B ...

Patients with large B-cell lymphoma (LBCL) who had stable or progressive disease at the end of treatment or relapsed within 3 months had markedly worse response rates and survival outcomes than those ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that ...